Sunbelt Securities’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$517 Hold
52
﹤0.01% 2285
2025
Q4
$440 Hold
52
﹤0.01% 2261
2025
Q3
$271 Buy
+52
New +$198 ﹤0.01% 2365

Other funds holding RLAY

Sunbelt Securities's RLAY Position: Q1 2026 in Review

Sunbelt Securities held its Relay Therapeutics (RLAY) position steady in Q1 2026 at 52 shares worth $517. The position accounts for ﹤0.01% of the portfolio, ranked #2285.

Sunbelt Securities first reported a position in RLAY in Q3 2025 and has held it in 3 quarters since. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Sunbelt Securities held 52 shares of Relay Therapeutics worth $517 as of Q1 2026.
  • Sunbelt Securities left its Relay Therapeutics share count unchanged in Q1 2026.
  • Relay Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2285 holding.
  • Sunbelt Securities first reported a position in Relay Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.